The WELBIO Investigator Program 2025, funded by the Walloon Region to support strategic research programs of excellence, has selected projects by Julien Guiot (Starting Grant), Pierre Close, Thomas Marichal, and Laurent Nguyen (Advanced Grants).
A study in The Journal of Experimental Medicine shows how circulating monocytes detect metabolic signals in the lung to locate macrophage niches and differentiate. The work reveals a potential therapeutic pathway to modulate lung immunity.
MafB, a key genetic regulator that enables macrophages to reach full maturity and preserve the health of our organs, opening up new therapeutic avenues for treating numerous chronic diseases.
Grégory receives an Incentive Grant for Scientific Research (MIS) from the FNRS to study the resistant leukemia cells responsible for relapses of acute myeloid leukemia and identify new avenues for improving treatments.
The Fondation Contre le Cancer is supporting the projects of Pierre Foidart, Céline Grégoire and Alexandra Veloso for a period of 4 years.
Congratulations to all researchers obtaining a new FNRS mandate !
Join us at GIGA DAY 2025 on September 12th !
Invited speakers : Michael Heneka | Frederic Kerff | Valentin Fischer | Olivier Malaise | Jingjing Zhu
This symposium is open to all. Registration is free but compulsory.
This prestigious scientific award, presented in the presence of HM the Queen, will help fund his research on respiratory physiology, particularly the role of pulmonary neutrophils.
A study led by Thomas Marichal's team reveals how signals from endothelial cells lining blood vessels guide the development of interstitial macrophages — immune cells essential for maintaining lung tissue integrity.
Researchers from Prof Julien Guiot's team at the Pneumology Laboratory have identified a molecular signature of microRNAs enabling early detection of lung damage in patients with systemic scleroderma.
The GIGA is part of an international research team aiming to advance prediction, early detection and personalized prevention in rheumatoid arthritis and inflammatory bowel disease.
A ULiège study has validated blood biomarkers predicting relapse in Crohn's disease. This prediction offers the hope of guiding therapeutic strategies according to the future progression of the disease.
